Last edition
News about "Neulasta biosimilar"
Biocon's Pegfilgrastim Biosimilar Gets Japan MHLW Approval
Biocon’s pegfilgrastim biosimilar receives Japan MHLW marketing approval, strengthening the company’s biosimilar portfolio and expanding access in Japan.
Neulasta Biosimilar | 25/08/2026 | By News Bureau
US FDA Approves Accord BioPharma's ENNUMO Pegfilgrastim Biosimilar
The US Food and Drug Administration (FDA) has approved Accord BioPharma’s ENNUMO (pegfilgrastim-pccg), expanding its US biosimilar portfolio and strengthening access to G-CSF therapies for cancer patients.
Neulasta Biosimilar | 10/07/2026 | By News Bureau | 109
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy